在肝癌中,CRKL通过结合和JNK/JUN通路激活来增强YAP信号
Marie C Wesener1, Sofia M E Weiler1, Michaela Bissinger1
1Institute of Pathology, University Hospital Heidelberg, 69120 Heidelberg, Germany.
International journal of molecular sciences
|August 10, 2024
概括
研究人员确定CRKL是肝癌中新的YAP调节器. 向CRKL或JNK/JUN通路可能会抑制YAP并改善肝癌患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞信号传递 细胞信号传递
背景情况:
- 河马通路,特别是YAP和TAZ,在肝脏瘤发生过程中至关重要.
- 针对YAP/TAZ的抑制剂正在临床试验中,但上游监管机构也提出了治疗目标.
- 肝细胞癌 (HCC) 的进展与失调的YAP/TAZ活性有关.
研究的目的:
- 为了识别HCC细胞中YAP/TAZ活性的新型调节剂.
- 调查CRKL在YAP调控和HCC进展中的作用.
- 探索针对CRKL或下游途径的治疗策略.
主要方法:
- 接近标签 (BioID) 与质谱相结合,以识别YAP交互伙伴.
- 在体外实验中评估CRKL在细胞存活和YAP结合中的功能.
- 在HCC患者数据中分析CRKL表达和与生存预后的相关性.
主要成果:
- CRKL被确定为HCC细胞中的YAP独有的相互作用伙伴.
- 在HCC患者中,高CRKL表达与YAP活性和低生存率相关.
- 通过JNK/JUN通路激活,CRKL促进HCC细胞生存和YAP转录.
- 动氨酸的破坏破坏了CRKL-YAP相互作用.
结论:
- CRKL是HCC中YAP活动的重要调节者,通过直接结合和JNK/JUN通路激活起作用.
- 准CRKL或JNK/JUN通路为HCC提供了一个潜在的治疗策略.
- CRKL代表了YAP活动和肝癌患者预后的有前途的生物标志物.
关键词:
AP1 AP1 AP1 AP1 AP1 AP1 AP1 AP1 AP1 AP1 AP1 AP1 AP1 AP1 AP1 AP1 AP1 AP1生物ID BioID 是一个生物ID.在CRK中,CRK就是CRK.在HCC中,HCC是HCC.河马河马是什么意思 海马河马是什么意思在MSMSMSMSMSMSMSMSMSMSMS中,我们可以看到我们的 TEAD TEAD 团队.c- 六月 这是一个很好的时刻.蛋白质组学 蛋白质组学幸存率 幸存率 生存率更多相关视频
07:39Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
45
10:32Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
Published on: December 19, 2019
10.8K
相关概念视频
MAPK Signaling Cascades
5.3K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.3K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
